Xabier Mielgo-Rubio

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Mitochondrial differentiation and biogeography of <i>Hyla meridionalis</i> (Anura: Hylidae): an unusual phylogeographical pattern

Ernesto Recuero, Ainhoa Iraola, Xabier Mielgo-Rubio et al. · Journal of Biogeography · 2007 · 117 citations

Life Sciences, Biology, Genetics +17

Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy

Luis J. Leandro‐García, Lucía Inglada‐Pérez, Guillermo Pita et al. · Journal of Medical Genetics · 2013 · 79 citations

Medicine, Genetics, Oncology +14

Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients

J. Garde, Paloma Martín-Martorell, María De Julián et al. · Clinical & Translational Oncology · 2018 · 56 citations

Medicine, Oncology, Pharmacotherapy +12

Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations

Mariona Riudavets, Édouard Auclin, Miguel Mosteiro et al. · European Journal of Cancer · 2022 · 53 citations · Full text

Medicine, Molecular Genetics, Oncology +13